Data-driven precision: artificial intelligence redefining immunoradiotherapy in advanced pancreatic cancer
Yao-Wen Liu, Xiao-Ding Men, Bin-Ru Di, Yu-Lin Lei, Li Xiang, Yu-Hao Luo · 2026
Read Data-driven precision: artificial intelligence redefining immunoradiotherapy in advanced pancreatic cancer by Yao-Wen Liu, Xiao-Ding Men, Bin-Ru Di, Yu-Lin Lei, Li Xiang, Yu-Hao Luo (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13194001.txt.
Description
Yao-Wen Liu, Xiao-Ding Men, Bin-Ru Di, Yu-Lin Lei, Li Xiang, and Yu-Hao Luo map how artificial intelligence could sharpen combined immune and radiation therapy for pancreatic cancer in this 2026 review. The cancer resists most treatment, wrapped in a suppressive neighborhood of cells that blunts immune attack.
Checkpoint drugs plus radiation help in some cancers but barely move this one, because tumors differ so much between and within patients. The authors propose AI that reads scans, dose maps, and molecular data together. Such models could sort tumors into targetable subtypes, tune dose and timing per patient, and adjust treatment as responses come in. Data scarcity and opaque models remain barriers, and the review ends with steps toward real clinical use.
Catalog record
| CREATOR | Yao-Wen Liu, Xiao-Ding Men, Bin-Ru Di, Yu-Lin Lei, Li Xiang, Yu-Hao Luo |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 22 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |